Meet the Sunnybrook
specialists at the
forefront of COVID-19
treatment and research
PAGE
MENU

Sunnybrook’s COVID-19 virtual panel discussions

Sunnybrook has been at the global forefront of the COVID-19 pandemic since the first Canadian case was identified. In a series of virtual panel discussions, Sunnybrook specialists shared information on the research and treatment currently underway and the impact on the future of the virus.

We invite you to view recordings of these sessions below, then provide your feedback by completing a short, one minute survey. We appreciate and value your input.

Session 2:

Watch a recording of our June 23 virtual panel discussion:

If you are unable to view the above video, please try watching on YouTube.

We hope you enjoyed the panel. Please provide your feedback by taking our one-minute survey.

Featuring:

  • Dr. Andy Smith, President & CEO of Sunnybrook
  • Dr. Robert Fowler, an epidemiologist and Chief of the Tory Trauma Program, will discuss his work leading one of Canada’s largest clinical drug trials and what we know about a possible second wave of COVID-19.
  • Dr. Jeannie Callum, a transfusion medicine specialist and Director of Utilization at the Department of Lab Medicine and Molecular Diagnostics, will share information on a Canada-wide clinical trial to test a potentially life-saving new treatment for COVID-19.

Session 1

Watch a recording of our June 9 virtual panel discussion:

If you are unable to view the above video, please try watching on YouTube. 

We hope you enjoyed the panel. Please provide your feedback by taking our one-minute survey.

Featuring:

  • Dr. Andy Smith, President & CEO of Sunnybrook
  • Dr. Jerome Leis, an infectious diseases physician, will lead a discussion on Sunnybrook’s collaboration with other organizations to ensure consistent and effective approaches to managing the virus and treating patients.
  • Dr. Samira Mubareka, Sunnybrook Translational Research Group for Emerging and Respiratory Viruses, will discuss Sunnybrook’s research response efforts since the earliest days of the pandemic and how understanding the virus at a granular level will help lead to treatment and impact public health.